nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicoumarol—NQO1—urinary bladder cancer	0.513	1	CbGaD
Dicoumarol—NQO1—Carboplatin—urinary bladder cancer	0.169	0.394	CbGbCtD
Dicoumarol—NQO1—Cisplatin—urinary bladder cancer	0.144	0.336	CbGbCtD
Dicoumarol—NQO1—Doxorubicin—urinary bladder cancer	0.0966	0.225	CbGbCtD
Dicoumarol—CYP2C9—Fluorouracil—urinary bladder cancer	0.0104	0.0243	CbGbCtD
Dicoumarol—CYP2C9—Cisplatin—urinary bladder cancer	0.00884	0.0206	CbGbCtD
Dicoumarol—CRYZ—prostate gland—urinary bladder cancer	0.0045	0.105	CbGeAlD
Dicoumarol—CRYZ—seminal vesicle—urinary bladder cancer	0.0038	0.0886	CbGeAlD
Dicoumarol—VKORC1—prostate gland—urinary bladder cancer	0.00309	0.0721	CbGeAlD
Dicoumarol—CRYZ—renal system—urinary bladder cancer	0.00306	0.0714	CbGeAlD
Dicoumarol—CRYZ—urethra—urinary bladder cancer	0.00301	0.0701	CbGeAlD
Dicoumarol—CYP2C9—urine—urinary bladder cancer	0.00255	0.0595	CbGeAlD
Dicoumarol—CRYZ—female reproductive system—urinary bladder cancer	0.00245	0.0572	CbGeAlD
Dicoumarol—CRYZ—vagina—urinary bladder cancer	0.00222	0.0517	CbGeAlD
Dicoumarol—VKORC1—renal system—urinary bladder cancer	0.00211	0.0491	CbGeAlD
Dicoumarol—NQO1—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.00204	0.15	CbGpPWpGaD
Dicoumarol—NQO1—prostate gland—urinary bladder cancer	0.00192	0.0447	CbGeAlD
Dicoumarol—VKORC1—female reproductive system—urinary bladder cancer	0.00169	0.0394	CbGeAlD
Dicoumarol—CRYZ—Azacitidine—Gemcitabine—urinary bladder cancer	0.00167	1	CbGdCrCtD
Dicoumarol—NQO1—seminal vesicle—urinary bladder cancer	0.00162	0.0378	CbGeAlD
Dicoumarol—CRYZ—lymph node—urinary bladder cancer	0.00144	0.0334	CbGeAlD
Dicoumarol—NQO1—epithelium—urinary bladder cancer	0.00141	0.0328	CbGeAlD
Dicoumarol—NQO1—smooth muscle tissue—urinary bladder cancer	0.00136	0.0316	CbGeAlD
Dicoumarol—NQO1—renal system—urinary bladder cancer	0.00131	0.0305	CbGeAlD
Dicoumarol—NQO1—urethra—urinary bladder cancer	0.00128	0.0299	CbGeAlD
Dicoumarol—NQO1—female reproductive system—urinary bladder cancer	0.00105	0.0244	CbGeAlD
Dicoumarol—VKORC1—lymph node—urinary bladder cancer	0.000988	0.023	CbGeAlD
Dicoumarol—NQO1—vagina—urinary bladder cancer	0.000947	0.0221	CbGeAlD
Dicoumarol—NQO1—lymph node—urinary bladder cancer	0.000613	0.0143	CbGeAlD
Dicoumarol—NQO1—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000604	0.0443	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—TP63—urinary bladder cancer	0.000514	0.0377	CbGpPWpGaD
Dicoumarol—CYP2C9—female reproductive system—urinary bladder cancer	0.0005	0.0117	CbGeAlD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000462	0.0339	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—IGFBP3—urinary bladder cancer	0.000404	0.0296	CbGpPWpGaD
Dicoumarol—NQO1—Oxidative Stress—SOD2—urinary bladder cancer	0.000403	0.0296	CbGpPWpGaD
Dicoumarol—CYP2C9—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.000399	0.0292	CbGpPWpGaD
Dicoumarol—NQO1—Oxidative Stress—GPX1—urinary bladder cancer	0.000385	0.0282	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—UGT2B7—urinary bladder cancer	0.000383	0.0281	CbGpPWpGaD
Dicoumarol—NQO1—Amino acid and derivative metabolism—GSTZ1—urinary bladder cancer	0.000361	0.0264	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—JAG1—urinary bladder cancer	0.000345	0.0253	CbGpPWpGaD
Dicoumarol—CYP2C9—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.000323	0.0237	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—urinary bladder cancer	0.000309	0.0227	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000244	0.0179	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—FAS—urinary bladder cancer	0.000225	0.0165	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000224	0.0164	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000196	0.0143	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000179	0.0131	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000161	0.0118	CbGpPWpGaD
Dicoumarol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000155	0.0114	CbGpPWpGaD
Dicoumarol—CYP2C9—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000153	0.0112	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—CDKN2A—urinary bladder cancer	0.000151	0.0111	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000149	0.0109	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—CDX2—urinary bladder cancer	0.000147	0.0108	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000141	0.0103	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000134	0.00981	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000134	0.00981	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.00013	0.00954	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.00013	0.00954	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000126	0.00921	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—CDKN1A—urinary bladder cancer	0.000126	0.0092	CbGpPWpGaD
Dicoumarol—CYP2C9—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000125	0.00917	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—CDKN1A—urinary bladder cancer	0.000124	0.00907	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—GSTP1—urinary bladder cancer	0.000123	0.00903	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—EP300—urinary bladder cancer	0.000118	0.00863	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000117	0.00855	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000114	0.00836	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000114	0.00836	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—GSTM1—urinary bladder cancer	0.000113	0.0083	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000109	0.00796	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000109	0.00796	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000108	0.0079	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—urinary bladder cancer	9.7e-05	0.00711	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	9.54e-05	0.00699	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—IGFBP3—urinary bladder cancer	9.23e-05	0.00677	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	9.16e-05	0.00671	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTZ1—urinary bladder cancer	8.55e-05	0.00627	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—GSTZ1—urinary bladder cancer	8.43e-05	0.00618	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTO2—urinary bladder cancer	8.1e-05	0.00594	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—NAT1—urinary bladder cancer	8.1e-05	0.00594	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—GSTO2—urinary bladder cancer	7.99e-05	0.00586	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—UGT2B7—urinary bladder cancer	7.41e-05	0.00543	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—UGT2B7—urinary bladder cancer	7.31e-05	0.00536	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—CYP4B1—urinary bladder cancer	6.67e-05	0.00489	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTZ1—urinary bladder cancer	6.62e-05	0.00485	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—CYP4B1—urinary bladder cancer	6.58e-05	0.00483	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTO2—urinary bladder cancer	6.28e-05	0.0046	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—NAT1—urinary bladder cancer	6.28e-05	0.0046	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	5.75e-05	0.00421	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—UGT2B7—urinary bladder cancer	5.74e-05	0.00421	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonic acid metabolism—GPX1—urinary bladder cancer	5.64e-05	0.00414	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CYP4B1—urinary bladder cancer	5.17e-05	0.00379	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—SLC19A1—urinary bladder cancer	4.88e-05	0.00358	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PRSS3—urinary bladder cancer	4.76e-05	0.00349	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	4.44e-05	0.00326	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	4.38e-05	0.00321	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—IGF1—urinary bladder cancer	3.9e-05	0.00286	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—TYMP—urinary bladder cancer	3.8e-05	0.00279	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	3.55e-05	0.0026	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	3.44e-05	0.00252	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—NAT2—urinary bladder cancer	3.44e-05	0.00252	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	3.32e-05	0.00244	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—CXCL8—urinary bladder cancer	3.14e-05	0.0023	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—RRM2—urinary bladder cancer	2.97e-05	0.00218	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ENO2—urinary bladder cancer	2.75e-05	0.00202	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—HPGDS—urinary bladder cancer	2.75e-05	0.00202	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTT1—urinary bladder cancer	2.67e-05	0.00196	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	2.56e-05	0.00188	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	2.39e-05	0.00175	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	2.35e-05	0.00173	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	2.19e-05	0.00161	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.16e-05	0.00159	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTP1—urinary bladder cancer	1.85e-05	0.00136	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—TYMS—urinary bladder cancer	1.72e-05	0.00126	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—NCOR1—urinary bladder cancer	1.7e-05	0.00125	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTM1—urinary bladder cancer	1.7e-05	0.00125	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GPX1—urinary bladder cancer	1.63e-05	0.00119	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ERCC2—urinary bladder cancer	1.6e-05	0.00117	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—MTHFR—urinary bladder cancer	1.5e-05	0.0011	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	1.46e-05	0.00107	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—NAT1—urinary bladder cancer	1.39e-05	0.00102	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	1.39e-05	0.00102	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.36e-05	0.000999	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	1.27e-05	0.000929	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PPARG—urinary bladder cancer	1.22e-05	0.000892	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CREBBP—urinary bladder cancer	1.17e-05	0.000857	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	1.14e-05	0.000837	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	1.08e-05	0.00079	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	1.05e-05	0.00077	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PTGS2—urinary bladder cancer	9.58e-06	0.000702	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.42e-06	0.000617	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—TYMP—urinary bladder cancer	8.4e-06	0.000616	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PTEN—urinary bladder cancer	8.35e-06	0.000612	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.07e-06	0.000591	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—EP300—urinary bladder cancer	7.97e-06	0.000584	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—NAT2—urinary bladder cancer	7.59e-06	0.000557	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—RRM2—urinary bladder cancer	6.56e-06	0.000481	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	6.07e-06	0.000445	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ENO2—urinary bladder cancer	6.07e-06	0.000445	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.04e-06	0.000442	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	5.89e-06	0.000432	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.8e-06	0.000425	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—NQO1—urinary bladder cancer	4.89e-06	0.000359	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.75e-06	0.000348	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.14e-06	0.000304	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	4.08e-06	0.000299	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.95e-06	0.000289	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—TYMS—urinary bladder cancer	3.79e-06	0.000278	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	3.75e-06	0.000275	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	3.75e-06	0.000275	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GPX1—urinary bladder cancer	3.59e-06	0.000263	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	3.53e-06	0.000258	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	3.31e-06	0.000243	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PPARG—urinary bladder cancer	2.69e-06	0.000197	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	2.58e-06	0.000189	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	2.11e-06	0.000155	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.84e-06	0.000135	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.76e-06	0.000129	CbGpPWpGaD
